Fertility Preservation for Chronic Conditions Act; enact
Impact
If enacted, HB1066 will significantly affect the insurance landscape in Georgia by ensuring that patients undergoing treatments with the potential to impair fertility will have access to necessary preservation services, including egg, sperm, embryo, and ovarian tissue cryopreservation. This policy aims to mitigate the emotional and financial burdens on individuals facing infertility as a result of their medical treatments. By formalizing coverage for these services, the bill aims to reflect evolving medical standards and the needs of patients with chronic conditions.
Summary
House Bill 1066, also referred to as the 'Fertility Preservation for Chronic Conditions Act,' is designed to amend the state's insurance laws to require health benefit policies to provide coverage for medically necessary expenses related to standard fertility preservation services. This legislation addresses situations where medical treatments like chemotherapy or surgery can directly or indirectly lead to iatrogenic infertility, defined as a fertility impairment resulting from medical interventions for conditions such as cancer or lupus. The bill mandates that all health benefit policies issued or renewed after July 1, 2025, include this critical coverage requirement.
Contention
During discussions surrounding HB1066, proponents emphasized the ethical imperative to support patients dealing with the dual challenges of serious medical conditions and the potential for fertility loss. However, some opponents raised concerns about the financial implications on insurance providers and potential impacts on overall health insurance premiums. The requirement for broader coverage could compel insurers to adjust their policies and pricing models, prompting debates about the sustainability and economic viability of such mandates in the state's insurance framework.
Insurance; medically necessary expenses for standard fertility preservation services when a medically necessary treatment for cancer, sickle cell disease, or lupus may directly or indirectly cause an impairment of fertility; require coverage
Insurance; medically necessary expenses for standard fertility preservation services when a medically necessary treatment for cancer, sickle cell disease, or lupus may directly or indirectly cause iatrogenic infertility; require coverage
Requires health insurance coverage of standard fertility preservation services for individuals with certain menstrual disorders resulting in infertility.
Requires health insurance coverage of standard fertility preservation services for individuals with certain menstrual disorders resulting in infertility.
Requires health insurance coverage of standard fertility preservation services for individuals with certain menstrual disorders resulting in infertility.
Requires health insurance coverage of standard fertility preservation services for individuals with certain menstrual disorders resulting in infertility.